Join the club for FREE to access the whole archive and other member benefits.

Gordon Lithgow

Professor at The Buck Institute

Runs a research group studying the basic biology of aging and age-related disease. Team has made seminal discoveries including the identification of small molecules that slow aging.

Lithgow received his PhD in Genetics from the University of Glasgow, Scotland.  He completed postdoctoral training at the Institute for Behavioral Genetics at the University of Colorado, Boulder.  Lithgow was a Senior Lecturer in Molecular Gerontology at the School of Biological Sciences at the University of Manchester in England before coming to the Buck Institute in 2001.  He is the Principal Investigator and Director of the Buck Institute’s Interdisciplinary Research Consortium on Geroscience. He is also the Principal Investigator of the Larry L. Hillblom Network on the Chemical Biology of Aging, and is the Coordinator of the Hillblom Center for the Biology of Aging Support Award.

Visit website:


See also: Institute Buck Institute - Independent biomedical research institute focused on aging

Details last updated 03-Sep-2020

Gordon Lithgow News

Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year


Body builder supplement AKG extends lifespan and healthspan of mice

Buck Institute - 01-Sep-2020

Blood levels fall with age. NUS planning a clinical trial with middle-aged humans.


Metformin human trials planned - 30-Nov-2015

Could significantly increase life expectancy and health span. 20 years ago aging was a biologica...

Topics mentioned on this page:
Ageing Research